BioAge Labs (BIOA) Accumulated Depreciation (2023 - 2026)

BioAge Labs has disclosed Accumulated Depreciation across 4 years of filings, most recently posting $613000.0 for Q2 2026.

• In Q2 2026, Accumulated Depreciation rose 32.68% year-over-year to $613000.0; the TTM figure through Jun 2026 stood at $613000.0 (up 32.68% YoY), while the FY2025 annual figure was $482000.0, up 29.92% from the prior year.
• Accumulated Depreciation came in at $613000.0 for Q2 2026 at BioAge Labs, up from $543000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $613000.0 in Q2 2026 to a low of $371000.0 in Q4 2024.
• Average Accumulated Depreciation over 4 years is $472333.3, with a median of $462000.0 recorded in 2025.
• Year-over-year, Accumulated Depreciation fell 23.52% in 2025 and soared 33.09% in 2026.
• Over 4 years, Accumulated Depreciation stood at $419000.0 in 2023, then dropped by 11.46% to $371000.0 in 2024, then climbed by 29.92% to $482000.0 in 2025, then grew by 27.18% to $613000.0 in 2026.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $613000.0 in Q2 2026, $543000.0 in Q1 2026, and $482000.0 in Q4 2025.